#anemia

The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.

Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.

Among the hep C population, other factors associated with chronic kidney disease include being older and having diabetes or HIV.

Will your hepatitis C treatment work if your doctor reduces your ribavirin dose?

The antiviral drug, which for some people can be a beneficial adjunct to the new crop of hep C medications, has gotten a bad rap.

The trial tested 16 and 24 weeks of grazoprevir/uprifosbuvir/ruzasvir among those with genotype 1 who had failed a previous treatment.

However, in a recent study those who had been treated for hep C before did not fare as well.

People on dialysis have a higher risk of anemia-related health complications if they have hepatitis C.

It’s been quite a ride. I can’t help but wonder what it’ll be like not to have ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin fl...

When I started Viekira Pak I wondered if the Week 3 voodoo would get me. It’s had a go, but failed so far. Here are the latest set of blood te...

A single pill of Sovaldi (sofosbuvir) and ledipasvir, with or without ribavirin, cured 96 percent of people with genotype 1 of HCV in...

Those taking AbbVie’s combo therapy virus who reduced their dose of ribavirin because of side effects, saw no reduction in their cure rates.

A novel version of interferon, pegylated interferon lambda-1a (peg-IFN-lambda), combined with ribavirin cured up to three-quarters of...